Bridge Medicines
Pre-clinicalTranslates early-stage biomedical discoveries from academic institutions into clinical-stage therapeutics.
Founded
2018
Focus
OncologyInfectious Disease
About
Translates early-stage biomedical discoveries from academic institutions into clinical-stage therapeutics.
Funding History
2Total raised: $138.5M
Series B$75MMPM CapitalMar 15, 2021
Series A$63.5MNovartis Venture FundJun 15, 2018
Company Info
TypePrivate
Founded2018
LocationNew York, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile